Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice. - Wikidata - awgldk - TriplyDB

Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice.

Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice.

http://www.wikidata.org/entity/Q34603941

about

Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus.Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice.Increased adiposity in annexin A1-deficient mice.Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes.Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.Deficiency of myotubularin-related protein 14 influences body weight, metabolism, and inflammation in an age-dependent manner.Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles.Circulating Galectin-3 Is Associated With Cardiometabolic Disease in the Community.New pathways to control inflammatory responses in adipose tissue.Adiponectin in inflammatory and immune-mediated diseases Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction.Galectin-3: an emerging all-out player in metabolic disorders and their complications.Maternal obesity is associated with ovarian inflammation and upregulation of early growth response factor 1.Galectin-3 inhibition prevents adipose tissue remodelling in obesity.Krüppel-like Factor 3 (KLF3/BKLF) Is Required for Widespread Repression of the Inflammatory Modulator Galectin-3 (Lgals3).Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease.Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets.Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.Targeted inhibition of galectin 1 by thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats.Relationship of galectin-3 with obesity, IL-6, and CRP in women.Galectin-12 enhances inflammation by promoting M1 polarization of macrophages and reduces insulin sensitivity in adipocytes.Antibiotic-Induced Alterations in Gut Microbiota Are Associated with Changes in Glucose Metabolism in Healthy Mice.Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.Functions of galectins as 'self/non-self'-recognition and effector factors.Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor?Mice lacking myotubularin-related protein 14 show accelerated high-fat diet-induced lipid accumulation and inflammation.Inflammation and insulin resistance: New targets encourage new thinking: Galectin-3 and LTB4 are pro-inflammatory molecules that can be targeted to restore insulin sensitivity.The metabolic response to a high-fat diet reveals obesity-prone and -resistant phenotypes in mice with distinct mRNA-seq transcriptome profiles.Krüppel-like factors: Crippling and un-crippling metabolic pathways.Mice lacking galectin-3 (Lgals3) function have decreased home cage movement.The Role of Galectins as Modulators of Metabolism and Inflammation.Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis

P2860

Q26771826-C0BFAAA7-9C37-4E9D-8D07-2085AE978638 Q28069174-4BFABF0F-DEF7-4DE0-B1DF-6629C2DD9700 Q34309578-CE0458BD-0ECB-4327-A376-0A298D466D08 Q34643771-504FCC8D-8C97-4403-B90B-E5FAC8A976C2 Q35061556-AEF576F7-48E2-4659-B546-904941427120 Q35842591-F6FDB832-9E59-44C8-96F9-A8888AEE5906 Q36025690-1A6D6AD7-1FE9-426B-9631-B7C7A942630F Q36393696-407A61DD-FD0A-424E-BB8D-7DEDAD5CCC0F Q36601648-071ED271-90C4-4605-B627-FB279D04D2A1 Q36877555-F705EABE-50E7-42E1-8876-160C50BEC439 Q37067301-1CBF6A65-4F04-49B0-A4DF-8A5DD6D05F19 Q37164707-37F1130C-CE7F-4494-9F6E-290E1DEE9436 Q38118993-5C82BF91-18BA-49AE-B667-A44909C833E3 Q38258947-A7EA1B74-E24F-4360-8115-BAC76C87C514 Q38292156-74817F4E-C933-45C5-974A-FA0D8765BF60 Q38382993-A977FA7F-70E4-490A-B41A-89584C999277 Q38862296-826CF33A-8553-41EF-894E-4C93BC95EE02 Q38945365-55D5EFB3-831D-494C-B540-72D72677DE86 Q41695164-77FF19CA-CA58-4D39-BC4E-38908C2A6BA6 Q42624178-117A0C81-D1E8-4F71-9E0E-880DD45F7868 Q42805774-1B1BE5FB-B277-46BB-828D-053463871938 Q42827891-F2301637-501E-46E1-A4CC-1C6DF666F107 Q46298007-C2E8A575-CC14-4BDE-A96E-B6E4EBB50F68 Q46507637-3E41CA44-E18C-4FE3-9AC4-2C082356DEF7 Q47130145-B2377C0D-185C-4D63-9FE6-81745154F90B Q47649685-77E6CAFC-427E-4EF3-BB66-1AF017E38739 Q47653100-2597159C-A765-4A0E-A152-AB843D537525 Q48159180-68EF3307-BD92-4827-8DF5-FC230BDFB9DE Q49989611-5B3E067E-9035-4B34-98F6-B501B2328FA0 Q51031908-4F0523B5-AB86-4364-8122-177CCE8A3845 Q51311008-3FDB0587-825B-4358-BA12-CA0F712A9B99 Q51347911-2B5796B3-B234-40FE-856E-6C62DF674CEC Q53137711-67FEE56E-44E0-4539-A55A-650EA28EDA57 Q53160248-5D46F1E1-EDA4-4430-A4A3-7300338E847B Q55079168-EC2CB92F-0F90-4EB6-BB1A-43EBA6C8D596 Q55308149-78274D7E-26B8-4B94-9C12-00F5C007DCF6 Q55349770-106B4DC8-56D9-4124-AFA5-7665D41CB1CC Q58762933-05B2843A-C8B9-4D3C-A933-FBD5B3C5C09F

P2860

Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice.

http://www.wikidata.org/entity/Q34603941

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@ast

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@en

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@nl

type

label

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@ast

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@en

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@nl

prefLabel

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@ast

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@en

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@nl

P1433

Q34603941-D471FB7B-CA65-4DAD-93DC-FAAB2C127CB9

P1476

Q34603941-C0EBFDF3-0426-4A6D-A4A2-243C3589407B

P2093

Q34603941-286F4219-9423-43C2-9DEE-5816777110A0

Q34603941-342CDFFC-51F9-44C9-8E0C-4ADA16F45DDE

Q34603941-51041078-4BA3-442B-865F-EC379947BF7D

Q34603941-8AAD747E-9322-4FE1-8721-7964802B38D1

Q34603941-B3B2602E-51BF-4DFB-933D-56C380FAFA48

Q34603941-B73F3139-5CCE-417B-9CE6-6A49E3982DA6

Q34603941-B8FBB0B3-0FA2-44D2-A9E5-F0D762AE23A0

Q34603941-D3CCBEF2-988D-45D1-AF51-12BC9A86D7DC

P2860

Q34603941-05B438E6-DF84-4AEA-8B3C-0CEAFB3A6E7D

Q34603941-0717897D-8FF6-4F60-8F3C-720430BF486A

Q34603941-08F69463-3B3A-4C16-B030-9B131AFC79E0

Q34603941-0D0EC71E-7041-4026-BE72-852FBEFC0A10

Q34603941-29CAEEDF-426A-4688-8AE3-E569D039001C

Q34603941-2B1CD2EA-74C5-44C5-9D5F-500C11EF183C

Q34603941-3044F5A0-82A9-41EF-9FD1-B36E46FC8E33

Q34603941-326C44D6-356C-4305-8172-BEC9EB0AEED3

Q34603941-342B2F4A-54D9-4690-A131-093CC2254596

Q34603941-372A7C8A-2D6F-4675-8141-E39ED3DB3DF6

P304

Q34603941-F191AD43-56E5-42F6-8BBD-57E71D327441

P31

Q34603941-D633A403-F945-4471-9B4B-221B356C5D11

P356

Q34603941-AD4932A4-C46C-4FF3-8F73-F28152909D40

P407

Q34603941-68F4612E-3408-42E2-AE2C-8F5FFADBC8C3

P433

Q34603941-A58FDA0F-CAA7-4A21-8DE0-F584DC08472F

P478

Q34603941-2DACBC57-3E18-4046-9F25-571A3F64A8F6

P50

Q34603941-EFAE24A8-4DF1-4382-8315-B35F1E2D75B9

P577

Q34603941-6FB97220-DBED-49C9-B727-5908CE79F3E9

P5875

Q34603941-D302F6FD-96B4-4A3F-9438-0D5A926FE9FA

P698

Q34603941-55D7DD49-8E62-49E8-9889-358C8B4A717D

P932

Q34603941-2A5A66EC-BF06-4DC7-90DF-D61BC74B9B23

P356

JOURNAL.PONE.0057915

P1433

P1476

Increased adiposity, dysregula ...... mmation in Galectin-3 KO mice.

@en

P2093

Davina H Rhodes

http://www.w3.org/2001/XMLSchema#string

Dianne Cooper

http://www.w3.org/2001/XMLSchema#string

Giamila Fantuzzi

http://www.w3.org/2001/XMLSchema#string

Jingbo Pang

http://www.w3.org/2001/XMLSchema#string

Karla J Castellanos

http://www.w3.org/2001/XMLSchema#string

Mauro Perretti

http://www.w3.org/2001/XMLSchema#string

Rand T Akasheh

http://www.w3.org/2001/XMLSchema#string

Robert J Cabay

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity is a fibroblast growth factor 21 (FGF21)-resistant state

The interaction of hepatic lipid and glucose metabolism in liver diseases

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex

Functional interactions between the gut microbiota and host metabolism

STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.

PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.

Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice.

Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice.

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.

P304

e57915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0057915

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235758021

http://www.w3.org/2001/XMLSchema#string

P698

23451284

http://www.w3.org/2001/XMLSchema#string

P932

3579848

http://www.w3.org/2001/XMLSchema#string